4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-052466
Chief Financial Officer acquired 80,366 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Horn Howard · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-10-09 | Grant or award : show line 1 in the form | +80,366 | 80,336 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-10-09 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +140,469 | 140,469 | D |
Loading xslF345X05/doc4.xml…